More than 4,400 lawsuits have been filed since millions of Americans embraced GLP-1 drugs like Ozempic, Wegovy and Mounjaro to lose weight.

A large multinational clinical trial has found that giving health care providers access to European Organization for Research ...

As with all medicines, beta blockers can produce certain unwanted effects. The NHS website recommends that patients should ...

As is the case with any medication, beta blockers can lead to some side effects. The NHS website urges people to “contact ...

People prescribed a particular medication are reminded to contact their GP if they develop certain side effects that "bother" ...

The popularity of GLP-1 weight-loss drugs has seen a seismic shift in just over a year. Not long ago, they were primarily used for diabetes. But now, that’s changing. In some markets, such as the US, ...

Kristie Reed, PharmD, oversees emergency, general medical, surgical, psychiatric care, and oncology medication as the pharmacy director of a community hospital. Dr. Reed specializes in IV medications.

Oprah Winfrey says her use of GLP-1s has helped her lose more than weight – she's also lost her desire for alcohol. Winfrey tells People that her days of being able to "outdrink everyone at the table" ...

Leigh Weddle, PharmD, is a licensed pharmacist with over 10 years of experience in retail and clinical settings. Fish oil is a dietary supplement rich in omega-3 fatty acids, which have been found to ...

Last month, the Trump administration announced major plans to slash prices of GLP-1s, including Ozempic, Wegovy, Zepbound, and Mounjaro. The agreement will lower prices of these medications from ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. While extensive studies have found Covid-19 vaccines to be safe, effective, and to ...

Q. I was on a 14-day course of prednisone for vertigo. Once I stopped, I had terrible withdrawal symptoms that have persisted for more than 10 days. Luckily, they are getting better, but I’m still ...